Эргомед Клиникал Рисеч

The ERGOMED Group is a pan-European Clinical Development Company, providing full clinical trial-related services to developers of medical drugs. ERGOMED can assist with strategic clinical development planning, individual study design, project management and monitoring, study site management, drug safety monitoring and pharmacovigilance, medical writing as well as data management, biostatistics, regulatory assistance and other services. In addition, ERGOMED has access to its own Phase 1 unit for healthy volunteer studies as well as those in special populations and early phase oncology studies.

With its headquarters in Frankfurt, Germany, and five operational centres in London, Zagreb, Novi Sad, Krakow, and San Antonio ERGOMED currently conducts operations in over 20 different European countries. ERGOMED specializes in the fields of Oncology/Hematology and Neurology, with added strengths in Endocrinology and Immunology. while retaining experience in many other therapeutic areas and indications.

ERGOMED provides clinical development services to some of the world’s largest pharmaceutical companies as well as to many small- and mid-sized drug development companies and has been responsible for the pivotal studies of several drugs including a number of oncologics which have gone on to receive European regulatory approval. ERGOMED’s success is due largely to its motivated, highly trained, experienced and dedicated workforce. The company has grown to around 90 employees, one-quarter of whom hold doctorates in medicine or the life sciences.

ERGOMED has never had a trial contract cancelled or suspended, many clients have signed up for repeat business. In fact, a significant minority of its contracted opportunities have come from ‘rescue’ operations, taking over clinical trial responsibilities from CROs which have not performed according to project plans or expectations. In addition, a number of referrals have come from other CROs with which ERGOMED has collaborated, an important indication of ‘peer certification’. Finally, ERGOMED has successfully passed all audits performed by its clients and by independent authorities.

While ERGOMED prides itself on providing services across the spectrum of the pharmaceutical industry, the company has particular experience in working with biotech. ERGOMED is well placed to partner emerging and developing companies in this sector.